01
Cash & equivalents increased 34.3%
Cash & equivalents changed +34.3% from the comparable as-filed period.
$14.6M→$19.6MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTCG Oncology, Inc.'s latest supported as-filed period reports net income of -$79.1M, 90.8% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +34.3% from the comparable as-filed period.
Net income changed -90.8% from the comparable as-filed period.
Operating income changed -77.3% from the comparable as-filed period.
Research & development changed +74.5% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
CGON · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-355561SEC ↗10-QAug 6, 2026Period Jun 30, 20260001193125-26-336918SEC ↗8-KAug 6, 2026Period Aug 6, 20260001193125-26-336886SEC ↗4Jul 17, 2026Period Jul 15, 20260001193125-26-307838SEC ↗4Jul 14, 2026Period Jul 10, 20260001193125-26-303188SEC ↗4Jun 29, 2026Period Jun 25, 20260001140361-26-026779SEC ↗4Jun 25, 2026Period Jun 24, 20260001193125-26-282861SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 14, 2026Filed Aug 18, 2026 | POST LEONARD EDirector | Option ExerciseDirect | 1,000 | $1 | $600 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | POST LEONARD EDirector | Open Market SaleDirect | 1,000 | $75 | $74,540 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 18, 2026 | POST LEONARD EDirector | Option ExerciseDirect | 1,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed +104.6% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-279543